Mild hypercortisolism couldmodulate the tumor microenvironment, and it is already observed that glucocorticoid receptor activation on specific hormone-dependent tumor entities (breast and prostate cancer) can inhibit tumor cell growth and proliferation [20,21]. Here, NR3C1 is linked to prostate cancer.